Home
overview

 Following on from the success of last year’s conference the SMi Group is pleased to announce the return of one of its flagship conferences. The 2nd Annual Parallel Trade Conference will take place on the 13th and 14th of February and promises to deliver specialised, targeted presentations analysing and explaining the radical changes that have occurred over the last year and predicting the likelihood of further changes.
   The enlargement of the EU has had an unprecedented effect on Parallel Trade, and the drive towards a single market is an issue provoking heated debate on both sides. Each view will be expertly and passionately defended.
   The cost of healthcare in the US will be one of the most crucial issues in the forthcoming presidential campaign, and the legalising of Parallel Trade will open up the world’s largest market to external traders. The relative merits and disadvantages this will have on the US and the rest of the world will be meticulously explained.
   The recent emergence of counterfeit drugs in the British supply chain has rocked the industry, some blaming parallel trade and some defending it as an extra layer of security. Both views will be analysed.

NEW SPEAKER CONFIRMED:

  • Jim Thompson, Chair, European Alliance for Access to Safe Medicines (EAASM)
Confirmed speakers:
  • Peter Pitts, President, Center for Medicine in the Public Interest (CMPI)
  • Janice Haigh, Director, European Price and Trade, Astellas
  • Heinz Kobelt, Secretary General, European Association of Euro-Pharmaceutical Companies (EAEPC)
  • John Newbold, Pharmacy Trade Sector Manager, Roche
  • W. Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions
  • Robert Burton, Director, Unique Solutions for Pharma
  • Duncan Curley, Director, Innovate Legal
  • Klaus Perera, Group Director, EMEA Strategic Alliances, IMS Health
  • Brian Lovatt, CEO, Vision Pricing and Reimbursement
  • Donald MacArthur, Independent Consultant, former Secretary General of the EAEPC
  • Maarten Meulenbelt, Partner, Howrey LLP
  • Keiron Sparrowhawk, Partner, Pricespective
  • John Jenkins, JJ Associates, and leader, BRIDGE Pharma Traceability Pilot
  • Michael Hansen, International Sales Manager, FractureCode

5 Key Benefits of Attending

• UNDERSTAND the consequences an EU single market would have on parallel trade

• HEAR WHAT a potential democratic victory will mean for parallel trade in the USA

• ANALYZE IF counterfeit drugs in the uk market is a one off or the shape of things to come?

• DISCUSS WHETHER parallel trade actually improves supply chain safety?

• BE AWARE OF HOW parallel trade impacts on pricing structures

This event is aimed at those with the following job titles, including;

• Director, Government Affairs
• Director, Market Access & Reimbursement
• Director, Federal Affairs
• Director, Global Supply Chain
• Director, Pricing & Reimbursement
• Director, Public Policy
• Director, Economics and Pricing Strategy
• Director, US Managed Markets
• Director, European Markets
• Director, Global Regulatory Affairs

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Donald MacArthur

Donald MacArthur, , Independent Consultant

9:10 THE CHANGING NATURE OF PARALLEL TRADE

Janice Haigh

Janice Haigh, Director European Price & Trade, Astellas Pharma Europe

  • EU enlargement – myths, realities and new complexities
  • The changing pharmaceutical industry – parallel trade in a more complex world
  • Strategies for the future – what works, what doesn’t and why

9:50 NEW TRENDS AND PERSPECTIVES IN THE EUROPEAN TRADE MARKET

Klaus Perera

Klaus Perera, Director, IMS Health

  • The European Parallel Trade market in 2007
  • Key trends and drivers
  • Challenges and outlook for 2008
  • 10:30 Morning Coffee

    11:00 SALE ALLOCATIONS – DO THEY REDUCE THE LEVEL OF PARALLEL TRADE?

    Keiron Sparrowhawk

    Keiron Sparrowhawk, Partner, Price Spective Limited

  • How do you know if an allocation system is required?
  • What analysis is required?
  • How and in which countries to implement?
  • What are the non-economic costs of allocation systems?
  • 11:40 CANADA/US PARALLEL TRADE: TRENDS & OUTLOOK

    W. Neil Palmer

    W. Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions

  • History and growth of Canada/US cross-border trade
  • Canadian and US industry responses
  • Impact on Canadian prices, reimbursement & distribution
  • US outlook for importation from Canada and Europe
  • Implications for pricing and reimbursement
  • 12:20 Networking Lunch

    13:50 USING ITEM LEVEL TRACK & TRACE TO UNDERSTAND DISTRIBUTION CHANNELS

    Michael  Hansen

    Michael Hansen, Internatinal Sales Manager, FractureCode Corporation

  • Adding a unique “fingerprint” at the item level.
  • Creating a product biography to understand distribution networks.
  • Securing primary packaging to protect consumer
  • 14:30 BALANCING HARMONY AND REALITY- THE PRICING ENVIRONMENT WITHIN THE EU

    Brian Lovatt

    Brian Lovatt, Managing Director & Chief Executive, Vision International Healthcare

    ·         The economics of parallel trade as a consequence of EU market environment
    ·         Tactical measures towards parallel trade implemented by the industry in the
               past and their results
    ·         Identifying intelligent long-term pricing strategies
    ·         Pricing and reimbursement workflows in practice

    15:10 Afternoon Tea

    15:40 DUAL PRICING IN SPAIN

    Donald MacArthur

    Donald MacArthur, , Independent Consultant

  • GSK's initiative
  • Pfizer's twin track approach
  • Other companies
  • Could this approach work in other parallel exporting countries?
  • What conclusion might the ECJ reach?
  • GSK's initiative
  • Pfizer's twin track approach
  • Other companies
  • Could this approach work in other parallel exporting countries?
  • What conclusion might the ECJ reach?
  • GSK's initiative
  • Pfizer's twin track approach
  • Other companies
  • Could this approach work in other parallel exporting countries?
  • What conclusion might the ECJ reach?
  • 16:20 COMPULSORY LICENSING AND PARALLEL TRADE- PROBLEMS OR SOLUTIONS?

    Duncan Curley

    Duncan Curley, Director, Innovate Legal Services Limited

  • The Access to Medicines debate
  • TRIPs and compulsory licensing: the current state of play
  •  Parallel imports: debunking the myths

  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    W. Neil Palmer

    W. Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions

    9:10 CAN PARALLEL TRADE ACTUALLY IMPROVE SUPPLY CHAIN SAFETY?

    Heinz Kobelt

    Heinz Kobelt, Secretary General, European Association of Euro-Pharmaceutical Companies

  • Requirements for Parallel-Traded Products
  • Requirements for Parallel Traders
  • Enabling recalls
  • An asset rather than a scourge

  • 10:30 Morning Coffee

    11:00 STOPPING ILLEGAL PARALLEL TRADE - A ROCHE CASE STUDY

    John Newbold

    John Newbold, Pharmacy Trade Sector Manager, F. Hoffmann-La Roche

  • Legal parallel trade is here to stay, but illegal parallel imports damage everyone
  • Roche's successful tactics to limit illegal parallel trade
  • 11:40 PARALLEL TRADE: FRIEND OR FOE?

    Robert Burton

    Robert Burton, Director, Unique Solutions for Pharma Ltd

  • The EU Treaty of Rome allows the free movement of people and goods: is constant legal challenge simply a drain on resources?
  • The UK is the most established market for PT, but other markets are catching up fast (including France!)
  • In isolation, quota management doesn't work! What is needed is a regional commercial strategy. Is your commercial strategy adopting a National or Regional view>
  • Until we are a United States of Europe, there will not be price uniformity. So what's your commercial strategy for the next 25 years based on that assumption?
  • 12:20 Networking Lunch

    13:50 PANEL DISCUSSION- EMERGING COUNTRIES AND THE FUTURE OF PARALLEL TRADE

    Janice Haigh

    Janice Haigh, Director European Price & Trade, Astellas Pharma Europe

  • The emergence on the world scene of China, Brazil, India and Russia
  • Ramifications for Parallel Trade
  • 14:30 WHAT A POTENTIAL DEMOCRATIC VICTORY WILL MEAN FOR PARALLEL TRADE IN THE USA

    Peter Pitts

    Peter Pitts, President, Center for Medicine in the Public Interest

  • Lifting the ban
  • An increase in Parallel Trade
  • Desire to lower costs
  • Repercussions for Canada
  • Repercussions for Europe

  • 15:10 Afternoon Tea

    15:40 THE PHARMA TRACEABILITY PILOT - MASS SERIALISATION FOR SAFER PARALLEL TRADE

    John Jenkins

    John Jenkins, , JJ Associates

  • About the BRIDGE project and the pilot
  • The benefits
  • Pilot experiences to date
  • The application to parallel trade
  • 16:20 REGULATORY ISSUES AND INTELLECTUAL PROPERTY RIGHTS

    Maarten Meulenbelt

    Maarten Meulenbelt, Partner, Howrey LLP

  • How the European courts are shaping the law on parallel trade
  • Gaining and withdrawing market authorisations
  • Eurogenerics - is there still a difference between generics and parallel imports?
  • Invoking trade mark rights - the state of play
  • Invoking patent rights - the exhaustion of rights rules and the accession treaty
  • Withdrawl of reference products and competition law - is the EU importing US rules?
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    +

    Workshops

    How to react to parallel trade
    Workshop

    How to react to parallel trade

    Crowne Plaza Hotel - The City
    12th February to 13th February 2008
    London, United Kingdom

    Crowne Plaza Hotel - The City

    19 New Bridge Street
    London EC4V 6DB
    United Kingdom

    Crowne Plaza Hotel - The City

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.